Appetite Control: Semaglutide helps regulate appetite by acting on the brains hunger centers, reducing cravings and promoting a sense of fullness after meals
Users with significant weight loss goals, metabolic syndrome, or type 2 diabetes that has not responded adequately to GLP-1 monotherapy may benefit from the additional GIP pathway activation
tirzepatide, sold by Eli Lilly as Zepbound and Mounjaro
A smaller tattoo is easier to keep clean and protected
The FDA has approved three GLP-1s in particular for both type 2 diabetes treatment and weight loss: Liraglutide (Saxenda, Victoza): While effective, this once-daily injection generally leads to more modest weight loss compared to newer options (its been around since 2014)
Ipamorelin has been studied at doses ranging from roughly 1 to 3 micrograms per kilogram subcutaneously